檢索結果 - Patrick G. Swann

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Methonium Compounds in the Treatment of Hypertension

    Methonium Compounds in the Treatment of Hypertension 由 S. Locket, Patrick G. Swann, W. S. M. Grieve

    出版 1951
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.

    Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. 由 Patrick G. Swann, Carole A. Parent, Martine Croset, Pierre Fonlupt, Michel Lagarde, D.L. Venton, Guy C. Le Breton

    出版 1990
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity

    Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity 由 Yongjie Zhou, Eric P. Hanson, Yiqing Chen, Kelly S. Magnuson, Min Chen, Patrick G. Swann, Ronald L. Wange, Paul S. Changelian, John J. O’Shea

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    A View on the Importance of “Multi-Attribute Method” for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy

    A View on the Importance of “Multi-Attribute Method” for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy 由 Richard S. Rogers, Michael J. Abernathy, Douglas D. Richardson, Jason C. Rouse, Justin B. Sperry, Patrick G. Swann, Jette Wypych, Christopher Yu, Li Zang, Rohini Deshpande

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

    Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays 由 C.T. Viswanathan, Surendra K. Bansal, Brian Booth, Anthony J. DeStefano, Mark J. Rose, Jeffrey Sailstad, Vinod P. Shah, Jerome P. Skelly, Patrick G. Swann, Russell Weiner

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality

    Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality 由 John F. Carpenter, Theodore W. Randolph, Wim Jiskoot, Daan J.A. Crommelin, C. Russell Middaugh, Gerhard Winter, Ying‐Xin Fan, Susan Kirshner, Daniela Verthelyi, Steven Kozlowski, Kathleen A. Clouse, Patrick G. Swann, Amy S. Rosenberg, Barry Cherney

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: